Literature DB >> 30281189

Predicting tubal factor infertility by using markers of humoral and cell-mediated immune response against Chlamydia trachomatis.

Tiina Rantsi1, Hanna Öhman2,3, Mirja Puolakkainen4, Aini Bloigu5, Jorma Paavonen1, Heljä-Marja Surcel2,3,5, Aila Tiitinen1, Päivi Joki-Korpela1.   

Abstract

PROBLEM: The accuracy of Chlamydia trachomatis antibody test in predicting tubal factor infertility (TFI) is limited, and more accurate methods are needed. Cell-mediated immune response (CMI) is crucial in the resolution of pathogen, but it may play an important role in the pathogenesis of C trachomatis-associated tubal damage. We studied whether combining the markers of C trachomatis-induced CMI to humoral immune response improves the accuracy of serology in TFI prediction. METHOD OF STUDY: Our prospective study consists of 258 subfertile women, of whom 22 (8.5%) had TFI. Women with other causes for subfertility served as a reference group. Serum C trachomatis major outer membrane protein (MOMP) and chlamydial heat-shock protein 60 (cHSP60) IgG antibodies were measured by ELISA. CMI was studied by lymphocyte proliferation assay in vitro.
RESULTS: Serological markers were more prevalent in women with TFI than in other subfertile women (40.9% vs 12.3% for MOMP IgG and 27.3% vs 10.2% for cHSP60 IgG). The best test combination for TFI was C. trachomatis MOMP and cHSP60 antibody with an accuracy of 90.3%, sensitivity of 22.7% and specificity of 96.6%. Positive post-test probability of this combination was 54.2%, and negative post-test probability was 12.4%. Adding of the markers of CMI did not significantly improve the accuracy of serology in TFI prediction.
CONCLUSION: The accuracy of TFI prediction increases when the combination of C trachomatis MOMP and cHSP60 antibody tests is used. C trachomatis-induced CMI was common in our study population, but the markers of CMI did not predict TFI.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Chlamydia trachomatiszzm321990; cell-mediated immune response; diagnostic test; serology; tubal evaluation; tubal factor infertility

Mesh:

Substances:

Year:  2018        PMID: 30281189     DOI: 10.1111/aji.13051

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  7 in total

Review 1.  What Can Serology Tell Us About the Burden of Infertility in Women Caused by Chlamydia?

Authors:  Patrick J Horner; Gloria E Anyalechi; William M Geisler
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 5.226

2.  Study on the Mechanism of Shenjing Guben Prescription Regulating PI3K and NRF2 Signaling Pathway in the Treatment of Immune Infertility.

Authors:  Handu Liu; Jianguo Xue; Hui Mo
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-13       Impact factor: 2.650

3.  High Plasmid Gene Protein 3 (Pgp3) Chlamydia trachomatis Seropositivity, Pelvic Inflammatory Disease, and Infertility Among Women, National Health and Nutrition Examination Survey, United States, 2013-2016.

Authors:  Gloria E Anyalechi; Jaeyoung Hong; Damien C Danavall; Diana L Martin; Sarah E Gwyn; Patrick J Horner; Brian H Raphael; Robert D Kirkcaldy; Ellen N Kersh; Kyle T Bernstein
Journal:  Clin Infect Dis       Date:  2021-10-20       Impact factor: 20.999

4.  Predictive Values of Serum Chlamydia trachomatis TroA and HtrA IgG Antibodies as Markers of Persistent Infection in the Detection of Pelvic Adhesions and Tubal Occlusion.

Authors:  Tiina Rantsi; Jolande A Land; Päivi Joki-Korpela; Sander Ouburg; Kati Hokynar; Jorma Paavonen; Aila Tiitinen; Mirja Puolakkainen
Journal:  Microorganisms       Date:  2019-09-25

5.  C-reactive protein as a marker of persistent Chlamydia trachomatis infection is not associated with tubal factor infertility-an independent clinical validation study.

Authors:  Me Jansen; Ef van Ess; S Ouburg; Ml Gerds; Sa Morré; Ja Land
Journal:  Hum Reprod Open       Date:  2019-12-16

Review 6.  Chlamydia trachomatis as a Current Health Problem: Challenges and Opportunities.

Authors:  Rafaela Rodrigues; Carlos Sousa; Nuno Vale
Journal:  Diagnostics (Basel)       Date:  2022-07-25

7.  Chlamydial Pgp3 Seropositivity and Population-Attributable Fraction Among Women With Tubal Factor Infertility.

Authors:  Gloria E Anyalechi; Jaeyoung Hong; Robert D Kirkcaldy; Harold C Wiesenfeld; Paddy Horner; Gillian S Wills; Myra O McClure; Karen R Hammond; Catherine L Haggerty; Dmitry M Kissin; Edward W Hook; Michael P Steinkampf; Kyle Bernstein; William M Geisler
Journal:  Sex Transm Dis       Date:  2021-03-31       Impact factor: 3.868

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.